Nicholas Plummer - 01 Nov 2022 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Reporting relationship: GC - Volition Diagnostics
Issuer ticker: VNRX
Reported as of: 01 Nov 2022
Net transaction value: -$18,530
SEC form: 4
Accepted by SEC: 03 Nov 2022, 16:01:16 UTC
Prior SEC filing: 14 Oct 2022
Next SEC filing: 12 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Nicholas Plummer

Key filing fact

Nicholas Plummer filed Form 4 for VOLITIONRX LTD (VNRX) on 03 Nov 2022.

Key facts

This page summarizes Nicholas Plummer's Form 4 filing for VOLITIONRX LTD (VNRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Nov 2022, 16:01.

Change

Previous filing in this sequence was filed on 14 Oct 2022.
Current net transaction value: -$18,530.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VNRX transaction

Common Stock

Tax liability

Transaction value: $18,530
Shares: -9,406
Change %: -17%
Price: $1.97
Shares after: 46,694
Date: 01 Nov 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 21,750 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.